We are live on ! Find out more
LIXTW

Lixte Biotechnology Warrants
LIXTW

Delisted

LIXTW was delisted on the 26th of November, 2025.

Back to rankings

2 hedge funds and large institutions have $1.44K invested in Lixte Biotechnology Warrants in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.63% less ownership

Funds ownership: 3.85% → 2.22% (-1.6%)

33% less funds holding

Funds holding: 3 → 2 (-1)

64% less capital invested

Capital invested by funds: $3.98K → $1.44K (-$2.54K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$1.6K
2
Citadel Advisors
Citadel Advisors
Florida
-$26
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$793 -$26 -809 -3%
CS
2
Clear Street
New York
$650 – – –
WAM
3
Warberg Asset Management
Illinois
– -$1.6K -35,906 Closed

LIXTW Hedge Fund Activity: Q4 2024 in Review

2 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q4 2024, worth a combined $1.44K — down 64% from $3.98K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of LIXTW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Warberg Asset Management, exiting entirely with an estimated $1.6K sold.

  • 2 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q4 2024, down from 3 in Q3 2024.
  • Funds reported $1.44K of Lixte Biotechnology Warrants stock for Q4 2024, down 64% quarter-over-quarter.
  • 0 funds opened new Lixte Biotechnology Warrants positions in Q4 2024 and 1 closed out, a net change of -1 holder.
  • The largest Lixte Biotechnology Warrants seller in Q4 2024 was Warberg Asset Management, an estimated $1.6K sold.

Based on aggregated 13F filings for Q4 2024.